Total Payments
$1,122
2024 Payments
$335.87
Companies
11
Transactions
17
Medicare Patients
2,600
Medicare Billing
$170,235
Payment Breakdown by Category
Food & Beverage$816.57 (72.8%)
Education$305.79 (27.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $816.57 | 12 | 72.8% |
| Education | $305.79 | 5 | 27.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $239.33 | 3 | $0 (2024) |
| Insmed, Inc. | $198.99 | 2 | $0 (2023) |
| GENZYME CORPORATION | $141.41 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $125.00 | 1 | $0 (2017) |
| United Therapeutics Corporation | $85.66 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $83.33 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $80.86 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $80.55 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $39.13 | 2 | $0 (2018) |
| Horizon Therapeutics plc | $25.94 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.87 | 6 | Actelion Pharmaceuticals US, Inc. ($122.66) |
| 2023 | $332.55 | 3 | GENZYME CORPORATION ($116.88) |
| 2022 | $163.88 | 2 | AstraZeneca Pharmaceuticals LP ($83.33) |
| 2021 | $125.93 | 3 | Insmed, Inc. ($99.99) |
| 2018 | $39.13 | 2 | Gilead Sciences, Inc. ($39.13) |
| 2017 | $125.00 | 1 | GlaxoSmithKline, LLC. ($125.00) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $92.40 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Immunology | ||||||
| 05/08/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $85.66 | General |
| 04/29/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: PULMONOLOGY | ||||||
| 02/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Cardiology | ||||||
| 08/23/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $116.88 | General |
| 05/03/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: Cardiology | ||||||
| 03/13/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Respiratory | ||||||
| 11/02/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $80.55 | General |
| Category: Oncology | ||||||
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: Respiratory | ||||||
| 12/09/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Respiratory | ||||||
| 10/19/2021 | Horizon Therapeutics plc | ACTIMMUNE (Drug) | Education | In-kind items and services | $12.97 | General |
| Category: ACTIMMUNE | ||||||
| 10/19/2021 | Horizon Therapeutics plc | ACTIMMUNE (Drug) | Education | In-kind items and services | $12.97 | General |
| Category: ACTIMMUNE | ||||||
| 09/20/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.13 | General |
| 02/28/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 05/11/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 782 | 919 | $207,635 | $48,224 |
| 2022 | 9 | 679 | 828 | $183,518 | $45,922 |
| 2021 | 9 | 568 | 699 | $157,061 | $41,452 |
| 2020 | 10 | 571 | 679 | $156,920 | $34,638 |
Total Patients
2,600
Total Services
3,125
Medicare Billing
$170,235
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 154 | 235 | $91,068 | $22,694 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 106 | 129 | $33,789 | $8,763 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 52 | $20,112 | $4,619 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $9,737 | $2,514 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $12,008 | $2,396 | 20.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 29 | 33 | $7,894 | $2,133 | 27.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 67 | 68 | $11,164 | $1,609 | 14.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 85 | 89 | $6,447 | $1,094 | 17.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 111 | 117 | $5,773 | $1,083 | 18.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 64 | 65 | $5,032 | $674.10 | 13.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 71 | 75 | $4,611 | $644.60 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 152 | 255 | $95,874 | $25,865 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 50 | $18,804 | $5,166 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 46 | 59 | $14,999 | $3,731 | 24.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 28 | 37 | $8,638 | $2,691 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 30 | $7,622 | $1,876 | 24.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 70 | 72 | $11,461 | $1,678 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $6,764 | $1,621 | 24.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 109 | 112 | $5,398 | $1,075 | 19.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 70 | 70 | $4,920 | $931.38 | 18.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 73 | 75 | $5,649 | $788.47 | 14.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 54 | 57 | $3,389 | $498.48 | 14.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 130 | 205 | $74,705 | $21,039 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 84 | 109 | $26,849 | $7,162 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 31 | $11,288 | $2,948 | 26.1% |
About Dr. John Clark, MD
Dr. John Clark, MD is a Pulmonary Disease healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518936871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Clark, MD has received a total of $1,122 in payments from pharmaceutical and medical device companies, with $335.87 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($816.57).
As a Medicare-enrolled provider, Clark has provided services to 2,600 Medicare beneficiaries, totaling 3,125 services with total Medicare billing of $170,235. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Anchorage, AK
- Active Since 03/17/2006
- Last Updated 08/26/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1518936871
Products in Payments
- UPTRAVI (Drug) $209.07
- Arikayce (Drug) $198.99
- ANORO ELLIPTA (Drug) $125.00
- DUPIXENT (Biological) $105.39
- TEZSPIRE (Biological) $83.33
- OPDIVO (Biological) $80.55
- OPSUMIT (Drug) $30.26
- ACTIMMUNE (Drug) $25.94
- CHARTIS CATHETER (Device) $22.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Anchorage
Marek Martynowicz, Md, MD
Pulmonary Disease — Payments: $13,937
Pulmonary Disease $13,937
Beth Baker, Md, MD
Pulmonary Disease — Payments: $796.55
Pulmonary Disease $796.55
Gregory Gerboth, Md, MD
Pulmonary Disease — Payments: $754.41
Pulmonary Disease $754.41
Denise Wurth, Md, MD
Pulmonary Disease — Payments: $421.14
Pulmonary Disease $421.14
David Zielke, Md, MD
Pulmonary Disease — Payments: $120.58
Pulmonary Disease $120.58
Dr. David Frankl, M.d., M.p.h, M.D., M.P.H
Pulmonary Disease — Payments: $67.76
Pulmonary Disease $67.76